Trial Profile
A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs CDX 1135 (Primary)
- Indications Membranoproliferative glomerulonephritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Celldex Therapeutics Inc
- 02 Apr 2014 New trial record
- 05 Mar 2014